A PAb240+ conformation of wild type p53 binds DNA

Oncogene

Volumn 13, Issue 6, 1996, Pages 1297-1303

  McLure, Kevin G ^a   Lee, Patrick W K ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

DNA binding; Dominant negative; p53 conformation; PAb 240

Indexed keywords

EPITOPE; PROTEIN P53;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONSENSUS SEQUENCE; DIMERIZATION; DNA SEQUENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DNA BINDING; RABBIT; RETICULOCYTE LYSATE;

ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES; CONSENSUS SEQUENCE; DNA; EPITOPES; MICE; PHENOTYPE; PROTEIN BINDING; PROTEIN CONFORMATION; RABBITS; RETICULOCYTES; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE; ORYCTOLAGUS CUNICULUS;

EID: 0029853272     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Chen J-Y, Funk WD, Wright WE, Shay JW and Minna JD. (1993). Oncogene, 8, 2159-2166
2. Chen Y, Chen P-L and Lee WH. (1994). Mol. Cell. Biol., 14, 6764-6772.
3. Cho Y, Gorina S, Jeffrey PD and Pavletich NP. (1994). Science, 265, 346-355.
4. Clore GM, Omichinski JG, Sakaguchi K, Zambrano N, Sakamoto H, Apella E and Gronenborn AM. (1994). Science, 265, 386-391.
5. Chodosh LA. (1991). Current Protocols in Molecular Biology. Ausubel FM et al., (ed.). Greene Pub. Associates: New York, pp. 12.2.3-12.2.7.
6. Cook A and Milner J. (1990). Br. J. Cancer, 61, 553-557.
7. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B. (1992). Nature Genet., 1, 45-49.
8. Freidman PN, Chen X, Bargonetti J and Prives C. (1993). Proc. Natl. Acad. Sci. USA, 90, 3319-3323.
9. Friend S. (1994). Science, 265, 334-335.
10. Funk WD, Pak DT, Karas RH, Wright WE and Shay JW. (1992). Mol. Cell. Biol., 12, 2866-2871.
11. Gannon JV, Greaves R, Iggo R and Lane DP. (1990). EMBO. J., 9, 1595-1602.
12. Hainaut P, Hall A and Milner J. (1994). Oncogene, 9, 299-303.
13. Hainaut P and Milner J. (1992). EMBO. J., 11, 3515-3520.
14. Hainaut P and Milner J. (1993). Cancer Res., 53, 4469-4473.
15. Hainaut P, Rolley N, Davies M and Milner J. (1995). Oncogene, 10, 27-32.
16. Halazonetis TD, Davis LJ and Kandil AN. (1993). EMBO. J., 12, 1021-1028.
17. Halazonetis TD and Kandil AN. (1993). EMBO. J., 12, 5057-5064.
18. Hall AR and Milner J. (1995). Oncogene, 10, 561-567.
19. Harlow E and Lane D. (eds) (1988). Antibodies: A Laboratory Manual. Cold Spring Harbour Laboratory: New York, pp. 309-311.
20. Hupp TR, Meek DW, Midgley CA and Lane DP. (1992). Cell, 71, 875-886.
21. Hupp TR, Sparks A and Lane DP. (1995). Cell, 83, 237-245.
22. Iwabuchi K, Bartel PL, Li B, Marraccino R and Fields S. (1994). Proc. Natl. Acad. Sci. USA, 91, 6098-6102.
23. Laemmli UK. (1970). Nature, 227, 680-685.
24. Milner J, Medcalf EA and Cook AC. (1991). Mol. Cell. Biol., 11, 12-19.
25. Milner J. (1995). TIBS 20, 49-51.
26. Milner J and Medcalf EA. (1990). J. Mol. Biol., 216, 481-484.
27. Milner J and Medcalf EA. (1991). Cell, 65, 765-774.
28. Prives C. (1994). Cell, 78, 543-546.
29. Stephan C and Lane DP. (1992). J. Mol. Biol., 225, 577-583.
30. Wang Y, Schwedes JF, Parks D, Mann K and Tegtmeyer P. (1995). Mol. Cell. Biol., 15, 2157-2165.
31. Wolkowicz R, Elkind NB, Ronen D and Rotter V. (1995). Oncogene, 10, 1167-1174.
32. Zambetti GP and Levine AJ. (1993). FASEB J., 7, 855-865.